| 摘要 |
<p>Methods, compounds, compositions and kits that relate to pretargeted delivery of diagnostic and therapeutic agents are disclosed. In particular, methods and agents for reducing the immunogenicity of targeting moiety-anti-ligand conjugates or other components employed in diagnostic and therapeutic pretargeting protocols.</p> |
